Allient Reports Fourth Quarter 2024 Results with Strengthening Orders and Margin Expansion

Rhea-AI Impact

(Neutral)

Rhea-AI Sentiment

(Neutral)

Insights

Allient's Q4 2024 results paint a picture of a company effectively managing through an industry-wide demand slowdown while positioning for future growth. Despite revenue declining 13% year-over-year to $122 million, the company maintained gross margins at 31.5% and improved them sequentially. More encouragingly, orders increased 15% sequentially, reaching a book-to-bill ratio near 1.0 – typically a leading indicator of stabilizing revenue.

The company's performance across market segments reveals a nuanced story: Aerospace & Defense (+20%) and Medical (+5%) showed strength, while Vehicle markets (-46%) and Industrial (-11%) continued to struggle with inventory destocking, particularly from Allient's largest customer. This market diversity is helping buffer overall performance.

On the operational front, Allient's "Simplify to Accelerate NOW" program delivered $10 million in annualized savings, demonstrating management's commitment to structural improvements. The additional $6-7 million in planned 2025 cost reductions, including the strategic Dothan facility transformation into a Machining Center of Excellence, should further enhance margins once implemented.

Financial health indicators remain solid with operating cash flow of $41.9 million for 2024 and debt reduction of $7.2 million in Q4 alone. The company's leverage ratio stands at 3.43x, which prompted a covenant amendment allowing for higher leverage in the near term – a prudent move providing flexibility through this transition period.

While current results reflect cyclical challenges, the sequential improvements in orders and margins, along with structural cost initiatives, signal Allient is executing effectively on controlling what it can while waiting for end markets to recover.

Allient's operational strategy demonstrates sophisticated adaptation to challenging market conditions. The company's ability to maintain 31.5% gross margins despite volume declines indicates effective cost management and production efficiency improvements. This is particularly notable given the substantial revenue drops in vehicle (46%) and industrial (11%) segments.

The company's Simplify to Accelerate NOW program appears to be delivering measurable results, with $10 million in annualized savings already achieved. The strategic decision to transform their Dothan, Alabama facility into a specialized Machining Center of Excellence while transferring assembly operations elsewhere represents textbook operational optimization – consolidating technical expertise while distributing standardized processes. The projected one-year payback period on this investment is aggressive but achievable based on the data provided.

Inventory management appears to be a significant external factor affecting performance, with the report explicitly mentioning "significant inventory destocking by the Company's largest customer" and "elevated inventory levels" affecting customer ordering patterns. This suggests Allient's operations team must carefully balance production capacity against fluctuating demand signals.

The sequential 15% order increase resulting in a book-to-bill ratio near 1.0 indicates operations will need to prepare for potential volume recovery. Meanwhile, the continued focus on extracting an additional $6-7 million in annual savings provides a clear roadmap for improving profitability even if revenue recovery remains gradual.

Cash generation of $41.9 million from operations demonstrates that underlying operational efficiency remains sound despite top-line challenges. The disciplined capital expenditure approach ($9.7 million in 2024) focused on supporting specific customer projects shows careful capacity allocation.

03/05/2025 - 04:43 PM

Fourth quarter revenue was $122.0 million, with gross margin improving sequentially to 31.5% despite lower revenue; Total orders increased 15% sequentially resulting in a book-to-bill ratio of nearly 1.00, driven by power quality and defense
Diluted earnings per share were $0.18 in the fourth quarter; Adjusted EPS was $0.31
Full year revenue of $530.0 million reflected anticipated demand softness in industrial and vehicle markets
Cash flow from operating activities was $41.9 million during 2024 and ended the year with $36.1 million of cash; Total debt reduced $7.2 million during the fourth quarter
The Simplify to Accelerate NOW program delivered $10 million in annualized savings in 2024
Additional cost savings are being implemented with a goal to reduce annualized costs by another $6-$7 million in 2025

BUFFALO, N.Y.--(BUSINESS WIRE)-- Allient Inc. (Nasdaq: ALNT) (“Allient” or the “Company”), a global designer and manufacturer of precision and specialty Motion, Controls and Power products and solutions for targeted industries and applications, today reported financial results for its fourth quarter and year ended December 31, 2024.

“We continue to drive operational improvements and margin expansion while navigating a dynamic demand environment,” said Dick Warzala, Chairman and CEO. “Notably, despite lower fourth quarter revenue, we delivered improved gross and operating margins, reflecting our continued focus on cost discipline and operational efficiency. At the same time, orders grew 15% sequentially, underscoring the strengthening demand in power quality and defense. While near-term order patterns remain fluid, the fundamental drivers of our business remain strong. These structural tailwinds reinforce our confidence in a return to more normalized run rates as customer inventory adjustments near completion.”

Mr. Warzala added, “Our Simplify to Accelerate NOW program continues to generate tangible results, delivering $10 million in annualized savings while enhancing our agility and competitiveness. Our goal in 2025 is to deliver an additional $6 million to $7 million in annual savings. In fact, our plans that we previously announced to create a state-of-the-art Machining Center of Excellence at our Dothan, Alabama facility while transferring current assembly operations to other facilities gives us a solid start toward that goal. While this transition presents complexities and requires focused execution, we are confident in the long-term efficiencies it will create. Implementation costs for the Dothan restructuring are expected to be equivalent to the annualized savings, resulting in a one-year pay back on the investment. We anticipate realizing the initial benefits of this initiative toward the end of 2025. Overall, our strategic initiatives position Allient for stronger financial performance, greater operational flexibility, and enhanced earnings power in the years ahead.”

Fourth Quarter 2024 Results (Narrative compares with prior-year period unless otherwise noted)

Revenue decreased 13%, or $19.0 million, to $122.0 million. The impact of foreign currency exchange rate fluctuations was unfavorable by $0.3 million. Sales to U.S. customers were 54% of total sales compared with 59% in the fourth quarter last year, with the balance of sales to customers primarily in Europe, Canada and Asia-Pacific. See the attached table for a description of non-GAAP financial measures and reconciliation of revenue excluding foreign currency exchange rate fluctuations.

Aerospace & Defense sales increased 20%, reflecting the timing of certain defense programs. Medical market revenue increased 5% on solid demand for surgical instruments, and respiratory and breathing demand. Sales in the Vehicle markets decreased 46% largely due to the decline in demand for powersports. Industrial markets sales were down 11% as strengthened power quality sales, largely to the HVAC/data center market, and incremental sales from the recent acquisition were more than offset by lower demand in industrial automation due to significant inventory destocking by the Company’s largest customer.

Gross margin was 31.5%, flat compared with the prior-year period, despite lower volume and the anticipated margin dilution from the most recent acquisition. Sequentially, gross margin improved 10 basis points, primarily driven by a more favorable product mix.

Operating costs and expenses were 26.2% of revenue, down 30 basis points year-over-year, primarily due to lower business development costs. As a result, operating income was $6.4 million compared with $7.0 million in the prior-year period, while operating margin improved 30 basis points to 5.3%.

The effective income tax rate was 22.2% in the fourth quarter compared with a tax benefit of $0.4 million in last year’s period, which reflected the realization of certain NOLs and R&D credits and incentives.

Net income was $3.0 million, or $0.18 per diluted share, compared with $4.3 million, or $0.26 per diluted share, in the prior-year period. Sequentially, net income improved from $2.1 million, or $0.13 per diluted share. Adjusted net income, which excludes amortization of intangible assets related to acquisitions, business development costs and other non-recurring items, was $5.2 million, or $0.31 per diluted share. This compared with $9.1 million, or $0.55 per diluted share, in the fourth quarter of 2023 and $5.1 million, or $0.31 per diluted share, in the third quarter of 2024. See the attached tables for a description of non-GAAP financial measures and reconciliation table for Adjusted Net Income and Diluted Earnings per Share.

Earnings before interest, taxes, depreciation, amortization, stock-based compensation expense, business development costs, foreign currency gains/losses, and restructuring and business realignment costs (“Adjusted EBITDA”) was $14.1 million, or 11.6% of revenue, compared with $16.9 million, or 12.0% of revenue. Sequentially, Adjusted EBITDA as a percentage of revenue was up 10 basis points. The Company believes that, when used in conjunction with measures prepared in accordance with U.S. generally accepted accounting principles, Adjusted EBITDA, which is a non-GAAP measure, helps in the understanding of its operating performance. See the attached table for a description of non-GAAP financial measures and reconciliation table for Adjusted EBITDA.

Full Year 2024 Results (Narrative compares with prior-year period unless otherwise noted)

Revenue of $530.0 million decreased $48.7 million, or 8%, primarily due to anticipated demand softness in industrial and vehicle markets, partially offset by continued strength in power quality solutions and incremental sales from acquisitions. The impact of foreign currency exchange rate fluctuations was unfavorable by $0.1 million. Sales to U.S. customers were 55% of total sales compared with 59% last year, with the balance of sales to customers primarily in Europe, Canada and Asia-Pacific.

Gross margin was 31.3%, down 40 basis points largely due to lower volume. Operating costs and expenses as a percentage of revenue were 25.6% compared with 24.4% last year, reflecting the loss of leverage on lower sales. As a result, operating income was $30.0 million, or 5.7% of sales, compared with $42.3 million or 7.3% of sales.

Net income was $13.2 million, or $0.79 per diluted share, compared with $24.1 million, or $1.48 per diluted share. The effective tax rate was 21.9% in 2024 compared with 18.9% in 2023. The Company expects its income tax rate for the full year 2025 to be approximately 21% to 23%.

Excluding amortization of intangible assets related to acquisitions, business development costs and other non-recurring items, adjusted net income was $24.7 million, or $1.49 per diluted share, compared with $37.5 million, or $2.30 per diluted share, in 2023.

Adjusted EBITDA was $62.5 million, and as a percentage of revenue was 11.8%.

Balance Sheet and Cash Flow Review

Cash and cash equivalents increased 13% to $36.1 million compared with $31.9 million at year-end 2023. Cash provided by operating activities was $41.9 million compared with $45.0 million last year.

Capital expenditures totaled $9.7 million for 2024, primarily supporting new customer projects. This compared with $11.6 million of capital expenditures in 2023. The Company expects 2025 capital expenditures to range between $10 million to $12 million.

Total debt of $224.2 million was down $7.2 million from the sequential third quarter. Debt, net of cash, was $188.1 million, or 41.5% of net debt to capitalization. The Company’s leverage ratio, as defined in its credit agreement, was 3.43x at year-end.

The Company amended its 2024 Amended Credit Agreement in the fourth quarter, increasing the maximum leverage ratio to 4.5:1.0 for the quarters ending March 31, 2025, and June 30, 2025, followed by 4.0:1.0 for the quarter ending September 30, 2025, before reverting to 3.75:1.0 thereafter. The amendment also allows for up to $4.0 million in specified costs to be added back to consolidated EBITDA.

Orders and Backlog Summary ($ in thousands)

	Q4 2024		Q3 2024		Q2 2024		Q1 2024		Q4 2023
Orders	$	117,900	$	102,631	$	137,373	$	122,127	$	105,162
Backlog	$	230,788	$	238,492	$	259,002	$	258,130	$	276,093

Fourth quarter orders increased 15% sequentially, primarily driven by strength in power quality and defense, and rose 12% year-over-year, reflecting similar end-market tailwinds as well as incremental contributions from a recent acquisition. Foreign currency translation had an unfavorable $0.6 million impact on fourth quarter orders compared with the prior-year period.

The sequential decline in backlog reflects temporary order softness, as customers continued to adjust ordering patterns in response to elevated inventory levels, and the effects of foreign currency exchange rate impacts. The majority of the backlog is expected to convert to revenue within three to nine months, in line with historical trends.

Conference Call and Webcast

The Company will host a conference call and webcast on Thursday, March 6, 2025, at 10:00 am ET. During the conference call, management will review the financial and operating results and discuss Allient’s corporate strategy and outlook. A question-and-answer session will follow.

To listen to the live call, dial (412) 317-0535. In addition, the webcast and slide presentation may be found at: allient.com/investors.

A telephonic replay will be available from 2:00 pm ET on the day of the call through Thursday, March 13, 2025. To listen to the archived call, dial (412) 317-6671 and enter replay pin number 10195875 or access the webcast replay via the Company’s website. A transcript will also be posted to the website once available.

About Allient Inc.

Allient (Nasdaq: ALNT) is a global engineering and manufacturing enterprise that develops solutions to drive the future of market-moving industries, including medical, life sciences, aerospace and defense, industrial automation, robotics, semi-conductor, transportation, agriculture, construction and facility infrastructure. A family of globally responsible companies, Allient takes a One-Team approach to “Connect What Matters” and provides the most robust, reliable, and high-value products and systems by utilizing its core Motion, Controls, and Power technologies and platforms.

Headquartered in Buffalo, N.Y., Allient employs more than 2,500 team members around the world. To learn more, visit www.allient.com.

Safe Harbor Statement

The statements in this news release that relate to future plans, events or performance are “forward-looking statements” within the meaning of the Private Securities Litigation Reform Act of 1995. Forward-looking statements include, without limitation, any statement that may predict, forecast, indicate, or imply future results, performance, or achievements. Examples of forward-looking statements include, among others, statements the Company makes regarding expected savings from restructuring and simplifying actions, the cost of implementing such actions, operating results, expectations for the level of sales, the Company’s belief that it has sufficient liquidity to fund its business operations, and expectations with respect to the conversion of backlog to sales. Forward-looking statements are neither historical facts nor assurances of future performance. Instead, they are based only on the Company’s current beliefs, expectations and assumptions regarding the future of the Company’s business, future plans and strategies, projections, anticipated events and trends, the economy and other future conditions. Because forward-looking statements relate to the future, they are subject to inherent uncertainties, risks and changes in circumstances that are difficult to predict and many of which are outside of the Company’s control. The Company’s actual results and financial condition may differ materially from those indicated in the forward-looking statements. Therefore, you should not rely on any of these forward-looking statements. Important factors that could cause our actual results and financial condition to differ materially from those indicated in the forward-looking statements include, among others, general economic and business conditions, conditions affecting the industries served by the Company and its subsidiaries, conditions affecting the Company's customers and suppliers, competitor responses to the Company's products and services, the overall market acceptance of such products and services, the pace of bookings relative to shipments, the ability to expand into new markets and geographic regions, the success in acquiring new business, the impact of changes in income tax rates or policies, commercial activity and demand across our and our customers’ businesses, global supply chains, the prices of our securities and the achievement of our strategic objectives, the ability to attract and retain qualified personnel, the ability to successfully integrate an acquired business into our business model without substantial costs, delays, or problems, and other factors disclosed in the Company's periodic reports filed with the Securities and Exchange Commission. Any forward-looking statement speaks only as of the date on which it is made. New risks and uncertainties arise over time, and it is not possible for us to predict the occurrence of those matters or the manner in which they may affect us. The Company has no obligation or intent to release publicly any revisions to any forward looking statements, whether as a result of new information, future events, or otherwise.

FINANCIAL TABLES FOLLOW

ALLIENT INC. CONDENSED CONSOLIDATED STATEMENTS OF INCOME *(In thousands, except per share data)* *(Unaudited)*

	For the three months ended					For the year ended
	December 31,					December 31,
		2024		2023		2024			2023
Revenue	$	122,010		$	140,997	$	529,968		$	578,634
Cost of goods sold		83,636			96,623		364,277			394,951
Gross profit		38,374			44,374		165,691			183,683
Operating costs and expenses:
Selling		6,027			6,359		25,310			24,713
General and administrative		13,231			14,779		55,669			58,403
Engineering and development		9,345			10,624		39,761			41,665
Business development		212			2,484		2,416			4,275
Amortization of intangible assets		3,116			3,087		12,497			12,313
Total operating costs and expenses		31,931			37,333		135,653			141,369
Operating income		6,443			7,041		30,038			42,314
Other expense, net:
Interest expense		3,089			3,074		13,296			12,383
Other (income) expense, net		(521	)		44		(116	)		231
Total other expense, net		2,568			3,118		13,180			12,614
Income before income taxes		3,875			3,923		16,858			29,700
Income tax (provision) benefit		(862	)		424		(3,692	)		(5,603	)
Net income	$	3,013		$	4,347	$	13,166		$	24,097
Basic earnings per share:
Earnings per share	$	0.18		$	0.27	$	0.80		$	1.51
Basic weighted average common shares		16,581			16,031		16,529			15,963
Diluted earnings per share:
Earnings per share	$	0.18		$	0.26	$	0.79		$	1.48
Diluted weighted average common shares		16,608			16,505		16,603			16,272

ALLIENT INC. CONDENSED CONSOLIDATED BALANCE SHEETS *(In thousands, except per share data)*

	December 31,
	2024		2023
Assets
Current assets:
Cash and cash equivalents	$	36,102	$	31,901
Trade receivables, net of provision for credit losses of $1,628 and $1,240 at December 31, 2024 and December 31, 2023, respectively		78,774		85,127
Inventories		111,517		117,686
Prepaid expenses and other assets		11,187		13,437
Total current assets		237,580		248,151
Property, plant, and equipment, net		65,685		67,463
Deferred income taxes		9,116		7,760
Intangible assets, net		99,671		111,373
Goodwill		131,789		131,338
Operating lease assets		23,748		24,032
Other long-term assets		8,192		7,425
Total Assets	$	575,781	$	597,542
Liabilities and Stockholders’ Equity
Current liabilities:
Accounts payable	$	27,156	$	39,129
Accrued liabilities		30,221		56,488
Total current liabilities		57,377		95,617
Long-term debt		224,177		218,402
Deferred income taxes		3,642		4,337
Pension and post-retirement obligations		1,667		2,679
Operating lease liabilities		19,417		19,532
Other long-term liabilities		4,647		5,400
Total liabilities		310,927		345,967
Stockholders’ Equity:
Common stock, no par value, authorized 50,000 shares; 16,810 and 16,308 shares issued and outstanding at December 31, 2024 and December 31, 2023, respectively		111,024		95,937
Preferred stock, par value $1.00 per share, authorized 5,000 shares; no shares issued or outstanding		—		—
Retained earnings		177,013		165,813
Accumulated other comprehensive loss		(23,183)		(10,175)
Total stockholders’ equity		264,854		251,575
Total Liabilities and Stockholders’ Equity	$	575,781	$	597,542

ALLIENT INC. CONDENSED CONSOLIDATED STATEMENTS OF CASH FLOWS *(In thousands)* *(Unaudited)*

	For the year ended
	December 31,		December 31,
	2024		2023
Cash Flows From Operating Activities:
Net income	$	13,166	$	24,097
Adjustments to reconcile net income to net cash provided by operating activities
Depreciation and amortization		25,891		25,068
Deferred income taxes		(2,353)		(5,036)
Stock-based compensation expense		4,147		5,477
Debt issue cost amortization recorded in interest expense		534		300
Other		4,824		1,424
Changes in operating assets and liabilities, net of acquisitions:
Trade receivables		7,455		(5,568)
Inventories		7,358		(1,781)
Prepaid expenses and other assets		2,412		1,324
Accounts payable		(12,755)		(935)
Accrued liabilities		(8,829)		(1,819)
Net cash provided by operating activities		41,850		45,038

Cash Flows From Investing Activities:
Consideration paid for acquisitions, net of cash acquired		(25,231)		(11,004)
Purchase of property and equipment		(9,683)		(11,603)
Net cash used in investing activities		(34,914)		(22,607)

Cash Flows From Financing Activities:
Proceeds from issuance of long-term debt		76,898		11,000
Principal payments of long-term debt and finance lease obligations		(68,433)		(28,395)
Payment of contingent consideration		(2,450)		—
Payment of debt issuance costs		(3,154)		—
Dividends paid to stockholders		(1,981)		(1,826)
Tax withholdings related to net share settlements of restricted stock		(1,723)		(2,096)
Net cash used in financing activities		(843)		(21,317)
Effect of foreign exchange rate changes on cash		(1,892)		173
Net increase in cash and cash equivalents		4,201		1,287
Cash and cash equivalents at beginning of period		31,901		30,614
Cash and cash equivalents at end of period	$	36,102	$	31,901

ALLIENT INC.
Reconciliation of Non-GAAP Financial Measures
(In thousands, Unaudited)

In addition to reporting revenue and net income, which are U.S. generally accepted accounting principle (“GAAP”) measures, the Company presents Revenue excluding foreign currency exchange rate impacts, Organic growth, and EBITDA and Adjusted EBITDA (earnings before interest, income taxes, depreciation and amortization, stock-based compensation expense, business development costs, and foreign currency gains/losses), which are non-GAAP measures. Business development costs include acquisition and integration related costs as well as restructuring and business realignment costs.

The Company believes that Revenue excluding foreign currency exchange rate impacts is a useful measure in analyzing organic sales results. The Company excludes the effect of currency translation from revenue for this measure because currency translation is not fully under management’s control, is subject to volatility and can obscure underlying business trends. The portion of revenue attributable to currency translation is calculated as the difference between the current period revenue and the current period revenue after applying foreign exchange rates from the prior period. Organic revenue is reported revenues adjusted for the impact of foreign currency and the revenue contribution from acquisitions.

The Company believes EBITDA and Adjusted EBITDA are often a useful measure of a Company’s operating performance and are a significant basis used by the Company’s management to evaluate and compare the core operating performance of its business from period to period by removing the impact of the capital structure (interest), tangible and intangible asset base (depreciation and amortization), taxes, stock-based compensation expense, business development costs, foreign currency gains/losses on short-term assets and liabilities, and other items that are not indicative of the Company’s core operating performance. EBITDA and Adjusted EBITDA do not represent and should not be considered as an alternative to net income, operating income, net cash provided by operating activities or any other measure for determining operating performance or liquidity that is calculated in accordance with GAAP.

The Company’s calculation of Revenue excluding foreign currency exchange impacts for the three and twelve months ended December 31, 2024 is as follows:

	Three Months Ended		Twelve Months Ended
	December 31, 2024		December 31, 2024
Revenue as reported	$	122,010	$	529,968
Foreign currency impact		295		139
Revenue excluding foreign currency exchange impacts	$	122,305	$	530,107

The Company’s calculation of organic growth for the three and twelve months ended December 31, 2024 is as follows:

	Three Months Ended	Twelve Months Ended
	December 31, 2024	December 31, 2024
Revenue decrease year over year	(13.5%)	(8.4%)
Less: Impact of acquisitions and foreign currency	6.8%	7.0%
Organic growth	(20.3%)	(15.4%)

The Company’s calculation of Adjusted EBITDA for the three and twelve months ended December 31, 2024 and 2023 is as follows:


	Three months ended				Twelve months ended
	December 31,				December 31,
	2024		2023		2024		2023
Net income as reported	$	3,013	$	4,347	$	13,166	$	24,097
Interest expense		3,089		3,074		13,296		12,383
Provision (benefit) for income tax		862		(424)		3,692		5,603
Depreciation and amortization		6,643		6,112		25,891		25,068
EBITDA		13,607		13,109		56,045		67,151
Stock-based compensation expense		765		1,312		4,147		5,477
Acquisition and integration-related costs		189		2,273		445		2,958
Restructuring and business realignment costs		23		211		1,971		1,317
Foreign currency (gain) / loss		(464)		24		(83)		281
Adjusted EBITDA	$	14,120	$	16,929	$	62,525	$	77,184

ALLIENT INC.
Reconciliation of GAAP Net Income and Diluted Earnings per Share to
Non-GAAP Adjusted Net Income and Adjusted Diluted Earnings per Share
(In thousands, except per share data)
(Unaudited)

The Company’s calculation of Adjusted net income and Adjusted diluted earnings per share for the three and twelve months ended December 31, 2024 and 2023 is as follows:


	For the three months ended
	December 31,
			Per diluted				Per diluted
	2024		share		2023		share
Net income as reported	$	3,013	$	0.18	$	4,347	$	0.26
Non-GAAP adjustments, net of tax (1)
Amortization of intangible assets – net		2,387		0.14		2,685		0.16
Foreign currency (gain) / loss – net		(355)		(0.02)		26		—
Acquisition and integration-related costs – net		145		0.01		1,844		0.11
Restructuring and business realignment costs – net		18		—		170		0.02
Non-GAAP adjusted net income and adjusted diluted earnings per share	$	5,208	$	0.31	$	9,072	$	0.55


	For the twelve months ended
	December 31,
			Per diluted				Per diluted
	2024		share		2023		share
Net income as reported	$	13,166	$	0.79	$	24,097	$	1.48
Non-GAAP adjustments, net of tax (1)
Amortization of intangible assets – net		9,726		0.59		9,752		0.60
Foreign currency (gain) / loss – net		(64)		—		223		0.01
Acquisition and integration-related costs – net		341		0.02		2,344		0.14
Restructuring and business realignment costs – net		1,510		0.09		1,042		0.06
Non-GAAP adjusted net income and adjusted diluted earnings per share	$	24,679	$	1.49	$	37,458	$	2.30

(1)	Applies a blended federal, state, and foreign tax rate of approximately 21% for 2023 and 23% for 2024 applicable to the non-GAAP adjustments.

Adjusted net income and diluted EPS are defined as net income as reported, adjusted for certain items, including amortization of intangible assets and unusual non-recurring items. Adjusted net income and diluted EPS are not a measure determined in accordance with GAAP in the United States, and may not be comparable to the measure as used by other companies. Nevertheless, the Company believes that providing non-GAAP information, such as adjusted net income and diluted EPS are important for investors and other readers of the Company’s financial statements and assists in understanding the comparison of the current quarter’s and current year’s net income and diluted EPS to the historical periods’ net income and diluted EPS.

View source version on businesswire.com: https://www.businesswire.com/news/home/20250305192525/en/

Investor Contacts:

Deborah K. Pawlowski / Craig P. Mychajluk

Alliance Advisors IR

716-843-3908 / 716-843-3832

dpawlowski@allianceadvisors.com / cmychajluk@allianceadvisors.com

Source: Allient Inc.

FAQ

What were Allient's (ALNT) Q4 2024 earnings per share?

Allient reported Q4 2024 diluted EPS of $0.18 and adjusted EPS of $0.31.

How much cost savings did ALNT's Simplify to Accelerate NOW program achieve in 2024?

The program delivered $10 million in annualized savings in 2024, with additional $6-7 million targeted for 2025.

What was Allient's (ALNT) order growth in Q4 2024?

Orders increased 15% sequentially and 12% year-over-year, driven by strength in power quality and defense sectors.

How much debt did Allient (ALNT) reduce in Q4 2024?

The company reduced total debt by $7.2 million in Q4 2024.

What was ALNT's revenue performance across different markets in Q4 2024?

Aerospace & Defense sales increased 20%, Medical market revenue grew 5%, Vehicle markets decreased 46%, and Industrial markets declined 11%.

Allient Reports Fourth Quarter 2024 Results with Strengthening Orders and Margin Expansion

Insights

FAQ

What were Allient's (ALNT) Q4 2024 earnings per share?

How much cost savings did ALNT's Simplify to Accelerate NOW program achieve in 2024?

What was Allient's (ALNT) order growth in Q4 2024?

How much debt did Allient (ALNT) reduce in Q4 2024?

What was ALNT's revenue performance across different markets in Q4 2024?

NASDAQ:ALNT

ALNT Rankings

ALNT Latest News

ALNT Stock Data

Trending News

Allient Reports Fourth Quarter 2024 Results with Strengthening Orders and Margin Expansion

Insights

Financial Analyst neutral

Operations Expert neutral

FAQ

What were Allient's (ALNT) Q4 2024 earnings per share?

How much cost savings did ALNT's Simplify to Accelerate NOW program achieve in 2024?

What was Allient's (ALNT) order growth in Q4 2024?

How much debt did Allient (ALNT) reduce in Q4 2024?

What was ALNT's revenue performance across different markets in Q4 2024?

NASDAQ:ALNT

ALNT Rankings

ALNT Latest News

ALNT Stock Data